resulted in significant increases in mortality and decreases in the time from infection to death. However, TCDD had no significant effect on mortality in the pseudorabies-infected mice. The most important finding in this study is that extremely low levels of TCDD, which do not produce clinical or pathological change, still have the capacity to affect host defense.
Various environmental chemicals have been shown to affect immune responses or host resistance to infectious agents (Friend and Trainer [6] , Gainer [81, Gainer and Pry [10] , Hemphill et al. [11] , Jones et al. [14] , Koller and Thigpen [191, Koller and Kovacic [18] , Koller [171, Verschuuren et al. [27] , Vos and van Genderen [30] , Vos et al. [291, Vos and Moore [28] , Wassermann et al. [32] ). These reports generally involve observed defects in antibody response (14, 17, 18, 19, 27, 30, 32) or on cell mediated immunity (28, 29, 30) , although several (6, 8, 10, 11) also describe suppressed host resistance to infection.
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) can occur as a highly toxic contaminant in the production of some chlorinated phenols or chemicals synthesized from chlorinated phenols such as the herbicide 2,4,5-trichlorophenoxyacetic acid and thus could be unknownly distributed in the environment. TCDD as an environmental contaminant can present health problems, both in man and other animals. It is associated with chloracne in man (16) and chick edema disease in chickens (5) . More recently TCDD and 2,4,5-trichlorophenol were implicated as the probable cause of toxicity in a group of horses in eastern Missouri. In addition to the horses, insects, birds, and rodents were poisoned, and there were several cases of human illness attributed to TCDD in this incident (3) .
TCDD has been observed to cause profound thymic atrophy and suppress cell-mediated immunity in rats, mice, and guina pigs (28, 29) . It is not known whether TCDD-exposed animals are more susceptible to infectious agents. These studies were designed to determine the effects of subclinical levels of TCDD on the response of mice subsequently infected with either Salmonella bern or pseudorabies virus (PRV). The criteria used to measure these effects were clinical appearance, weight gains, mortality rates, time from infection to death, and pathological examination.
MATERIALS AND METHODS
Animal. Four-week-old male C57BL/6Jfh (J67) specific-pathogen-free mice were purchased from Jackson Laboratories, Bar Harbor, Me In the first experiment, each mouse received either 0, 5, 10, or 20 ,ug of TCDD/kg per week. Two days after the last dose of TCDD, when the mice were 8 weeks old, each group was randomly divided into three subgroups. Mice in one subgroup were injected i.p. with 10' viable S. bern organisms (LD20114 dose), the second subgroup received 104 TCID of PRV (LD2014 dose), and the third subgroup (control) was injected with saline only. (LD204,, is the number of bacterial or viral agents required to kill approximately 20% of the mice inoculated within a 14-day observation period.)
The second experiment was conducted in a manner identical to the first except that each mouse received either 0, 0.5, 1, or 5 jig of TCDD/kg per week and the PRV subgroup was eliminated.
Both experiments were performed as blind studies, and the order of inoculation was randomized. Neither the bacterium nor the virus appeared to lose or gain potency during the time of administration. The level of mortality seen in the final 25% of the animals inoculated was not statistically different from that observed in the first 25% or the middle 50%. Therefore, the order of inoculation was virtually irrelevant to subsequent survival.
After bacterial and viral challenge, the animals were observed at least twice daily for 14 days. Body weights were recorded at death or at termination of the study. Necropsies were performed on at least three mice from each subgroup, and selected tissues were obtained for histopathological and microbiological examination. Mice from subgroups with less than three deaths were sacrificed and necropsied on day 14. The tissues selected for histopathological exami- Mortality rates in the bacteria and virus control groups that had not received TCDD were as anticipated based on the LD2014 preliminary study ( Table 2 ). The groups of mice exposed to 1, 5, 10, or 20 ,ug of TCDD per kg and given S. bern showed a significant (P < 0.05 to 0.01) increase in mortality rates. The mortality rate the control group; therefore, the "no effect" level based on the parameters of this study would be somewhere between 0.5 and 1.0 ,ug of TCDD per kg (Table 2 ; Fig. 1 ).
The mortality rates in the groups that re- The lesions described were still apparent in the mice from the two highest dose groups inoculated with virus or bacteria (both survivors and nonsurvivors). In addition, mice in the bacterial groups that died showed macro-and microscopic lesions typical of salmonellosis (1, 26) . There was widespread infiltration of polymorphonuclear leukocytes, particularly in visceral organs. Focal necrotic hepatitis resembling microinfarction was attributed to adjacent areas of vasculitis and thrombosis. Lymphoid necrosis, thrombotic vasculitis, and suppuration were also observed in the spleen. Necrotic enteritis, purulent peritonitis, and occasionally suppurative meningitis were also noted.
In the virus portion of the experiment, lesions attributable to PRV were not observed in any of the mice examined. PRV in laboratory rodents is known to produce few lesions at the light microscopic level (21) .
DISCUSSION
The data presented in this study clearly established that mice exposed to four weekly doses of 1, 5, 10, or 20 ,ug of TCDD per kg and subsequently infected with an LD20/14 dose of S. bern have a significantly higher rate of mortality with a shortened incubation period. Furthermore, the mice exposed to 1 or 5 ,ug of TCDD per kg appeared clinically normal, had a normal rate of weight gain, and showed no histopathological evidence of toxicity. This demonstrates the most important aspect of this study, i.e., that extremely low levels of TCDD which do not produce clinical or pathological change still have the capacity to affect host defense. These findings are significant in that humans may be exposed to environmental contaminants such as TCDD in minute quantities and therefore may be rendered more susceptible to certain types of infectious agents.
The fact that TCDD did not increase mortality in mice challenged with PRV suggests a difference in the pathogenesis of these two agents. The reason(s) for this difference is not understood.
There are several host defense factors which could account for the increased susceptibility to a facultative intracellular organism such as S. bern. These include: (i) a defect in cell-mediated immunity either through loss of mediating cells or by inhibition of cell function; (ii) a defect on the humoral system; (iii) a defect in one or more of the steps of phagocytosis; and (iv) a reduction or loss of phagocytic cells.
Cell-mediated immune reactions as evidenced by delayed hypersensitivity have been shown to play an important role in immunity and recovery from infections with salmonella and other facultative intracellular organisms (4, 15, 20, 22, 23, 25) . Delayed hypersensitivity is thought to be mediated through production of lymphokines by specifically activated T cells in response to bacterial antigens (4, 20, 22, 23, 25) . TCDD has been shown to suppress delayed hypersensitivity reactions and responses of T cells to activation by the mitogens concanavalin A and phytohemagglutinin (28, 29) . These studies did not investigate the influence of TCDD on lymphokine production, but it would be surprising if TCDD did not also suppress their production since it has such a profound effect on other T-cell function.
Humoral factors do not appear to be dominant in impaired host resistance to salmonella infection in mice since full protection from challenge appears to depend upon the immune response that leads to delayed-type hypersensitivity, rather than to that which results in circulating antibody and arthus sensitivity (4) . The effect of TCDD on humoral antibody production in mice is not known. Recent studies by one of the authors (R. E. Faith, unpublished data)
indicates that TCDD has no effect on humoral antibody production to bovine gamma globulin in rats. In contrast, the guinea pig humoral response to tetanus toxoid was observed to be impaired (Vos et al. [29] (33) indicated no significant change in peripheral blood monocyte numbers in rats treated with TCDD. In addition, these authors report an elevation in peripheral blood neutrophil counts after TCDD treatment. This would suggest that the defect in host resistance is not the result of destruction of circulating phagocytes. However, this does not rule out the possibility of death or destruction of tissue-fixed macrophages. The number of circulating monocytes is small in relation to those that are tissue fixed, and the study of circulating monocytes does not necessarily reflect the state of production or function of mononuclear phagocytes. In this light, it is of interest to note the results of two studies (7, 24) which show that treatment with agents that interfere with monocyte production also suppress host resistance to bacterial infection.
Studies designed to investigate the possibilities of alteration in functional abilities of phagocytic cells and production of monocytes in relation to dioxin exposure are being undertaken in this laboratory. In addition, possible defect(s) in cooperation between T cells and phagocytic cells are being investigated. The results of these studies should lend insight into the mechanism(s) of suppressed host resistance to infection induced by exposure to TCDD.
